This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heelan, J. S.
Right arrow Articles by McAdam, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heelan, J. S.
Right arrow Articles by McAdam, A. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2004, p. 1263-1264, Vol. 42, No. 3
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.3.1263-1264.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Resistance of Group B Streptococcus to Selected Antibiotics, Including Erythromycin and Clindamycin

Judith S. Heelan,1* Meredith E. Hasenbein,2 and Alexander J. McAdam2

Department of Microbiology, Memorial Hospital of Rhode Island, Pawtucket, and Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island,1 Department of Laboratory Medicine, Children's Hospital Boston, Boston, Massachusetts2

Received 31 July 2003/ Returned for modification 26 September 2003/ Accepted 11 November 2003

Resistance of group B streptococcus (GBS) to antibiotics, particularly erythromycin and clindamycin, was studied. Erythromycin resistance was present in 22% of GBS isolates, and these isolates were constitutively resistant, inducibly resistant, or sensitive to clindamycin. Erythromycin and clindamycin MICs were related to the presence of ermA, ermB, or mefA genes.


* Corresponding author. Mailing address: Department of Microbiology, Memorial Hospital of Rhode Island, 111 Brewster St., Pawtucket, RI 20860. Phone: (401) 729-2839. Fax: (401) 729-2990. E-mail: jheelan{at}mhri.org.


Journal of Clinical Microbiology, March 2004, p. 1263-1264, Vol. 42, No. 3
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.3.1263-1264.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Morrissey, I., Maher, K., Hawser, S. (2009). Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae. J Antimicrob Chemother 63: 413-414 [Full Text]  
  • Nagano, N., Nagano, Y., Kimura, K., Tamai, K., Yanagisawa, H., Arakawa, Y. (2008). Genetic Heterogeneity in pbp Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin Susceptibility. Antimicrob. Agents Chemother. 52: 4258-4267 [Abstract] [Full Text]  
  • Puopolo, K. M., Klinzing, D. C., Lin, M. P., Yesucevitz, D. L., Cieslewicz, M. J. (2007). A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus. J Med Microbiol 56: 947-955 [Abstract] [Full Text]  
  • Tazi, A., Reglier-Poupet, H., Raymond, J., Adam, J.-M., Trieu-Cuot, P., Poyart, C. (2007). Comparative evaluation of VITEK 2(R) for antimicrobial susceptibility testing of group B Streptococcus. J Antimicrob Chemother 59: 1109-1113 [Abstract] [Full Text]  
  • Wehbeh, W., Rojas-Diaz, R., Li, X., Mariano, N., Grenner, L., Segal-Maurer, S., Tommasulo, B., Drlica, K., Urban, C., Rahal, J. J. (2005). Fluoroquinolone-Resistant Streptococcus agalactiae: Epidemiology and Mechanism of Resistance. Antimicrob. Agents Chemother. 49: 2495-2497 [Abstract] [Full Text]  
  • Gonzalez, J. J., Andreu, A., the Spanish Group for the Study of Perinatal Infec, (2005). Multicenter Study of the Mechanisms of Resistance and Clonal Relationships of Streptococcus agalactiae Isolates Resistant to Macrolides, Lincosamides, and Ketolides in Spain. Antimicrob. Agents Chemother. 49: 2525-2527 [Abstract] [Full Text]